Relationship Between Mortality and Cancer-Bearing Status at Time of Dialysis Initiation

Akihito Tanaka, Daijo Inaguma, Hibiki Shinjo, Minako Murata, Asami Takeda

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Patients with malignancy are reported to have poorer prognosis than those without malignancy. When patients with malignancy develop end-stage kidney disease, clinicians must determine treatment with consideration of prognosis. Furthermore, malignancy is sometimes found at time of dialysis initiation. However, prognosis of patients with malignancy at time of dialysis initiation has not been investigated. A total of 1524 patients with chronic kidney disease who initiated dialysis at 17 centers participating in the Aichi Cohort Study of Prognosis in Patients Newly Initiated into Dialysis were included. Patients initiated dialysis between October 2011 and September 2013. Mortality rates were compared between patients with and without malignancy. Types of malignancy and respective prognoses also were assessed. The study included 1030 men and 492 women with a mean age of 67.5 ± 13.1 years. Of these, 92 had malignancy and 1430 did not; 45.7% of the former group and 16.0% of the latter group died by March 2015 (P < 0.01). Even after adjusting for various factors, presence of malignancy remained an independent risk factor for mortality (P < 0.01). Patients with performance status (PS) of 0 had significantly lower mortality (P < 0.01). Patients with malignancy at time of dialysis initiation had poor prognosis. Therefore, presence of malignancy should be taken into consideration when patients initiate dialysis. In patients with malignancy, better PS was associated with better prognosis.

Original languageEnglish
Pages (from-to)345-353
Number of pages9
JournalTherapeutic Apheresis and Dialysis
Volume21
Issue number4
DOIs
Publication statusPublished - 01-08-2017

Fingerprint

Dialysis
Mortality
Neoplasms
Chronic Renal Insufficiency
Chronic Kidney Failure
Cohort Studies

All Science Journal Classification (ASJC) codes

  • Hematology
  • Nephrology

Cite this

Tanaka, Akihito ; Inaguma, Daijo ; Shinjo, Hibiki ; Murata, Minako ; Takeda, Asami. / Relationship Between Mortality and Cancer-Bearing Status at Time of Dialysis Initiation. In: Therapeutic Apheresis and Dialysis. 2017 ; Vol. 21, No. 4. pp. 345-353.
@article{23cdd3a4a82140d3b0a8107470ea6cd9,
title = "Relationship Between Mortality and Cancer-Bearing Status at Time of Dialysis Initiation",
abstract = "Patients with malignancy are reported to have poorer prognosis than those without malignancy. When patients with malignancy develop end-stage kidney disease, clinicians must determine treatment with consideration of prognosis. Furthermore, malignancy is sometimes found at time of dialysis initiation. However, prognosis of patients with malignancy at time of dialysis initiation has not been investigated. A total of 1524 patients with chronic kidney disease who initiated dialysis at 17 centers participating in the Aichi Cohort Study of Prognosis in Patients Newly Initiated into Dialysis were included. Patients initiated dialysis between October 2011 and September 2013. Mortality rates were compared between patients with and without malignancy. Types of malignancy and respective prognoses also were assessed. The study included 1030 men and 492 women with a mean age of 67.5 ± 13.1 years. Of these, 92 had malignancy and 1430 did not; 45.7{\%} of the former group and 16.0{\%} of the latter group died by March 2015 (P < 0.01). Even after adjusting for various factors, presence of malignancy remained an independent risk factor for mortality (P < 0.01). Patients with performance status (PS) of 0 had significantly lower mortality (P < 0.01). Patients with malignancy at time of dialysis initiation had poor prognosis. Therefore, presence of malignancy should be taken into consideration when patients initiate dialysis. In patients with malignancy, better PS was associated with better prognosis.",
author = "Akihito Tanaka and Daijo Inaguma and Hibiki Shinjo and Minako Murata and Asami Takeda",
year = "2017",
month = "8",
day = "1",
doi = "10.1111/1744-9987.12525",
language = "English",
volume = "21",
pages = "345--353",
journal = "Therapeutic Apheresis and Dialysis",
issn = "1744-9979",
publisher = "Wiley-Blackwell",
number = "4",

}

Relationship Between Mortality and Cancer-Bearing Status at Time of Dialysis Initiation. / Tanaka, Akihito; Inaguma, Daijo; Shinjo, Hibiki; Murata, Minako; Takeda, Asami.

In: Therapeutic Apheresis and Dialysis, Vol. 21, No. 4, 01.08.2017, p. 345-353.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Relationship Between Mortality and Cancer-Bearing Status at Time of Dialysis Initiation

AU - Tanaka, Akihito

AU - Inaguma, Daijo

AU - Shinjo, Hibiki

AU - Murata, Minako

AU - Takeda, Asami

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Patients with malignancy are reported to have poorer prognosis than those without malignancy. When patients with malignancy develop end-stage kidney disease, clinicians must determine treatment with consideration of prognosis. Furthermore, malignancy is sometimes found at time of dialysis initiation. However, prognosis of patients with malignancy at time of dialysis initiation has not been investigated. A total of 1524 patients with chronic kidney disease who initiated dialysis at 17 centers participating in the Aichi Cohort Study of Prognosis in Patients Newly Initiated into Dialysis were included. Patients initiated dialysis between October 2011 and September 2013. Mortality rates were compared between patients with and without malignancy. Types of malignancy and respective prognoses also were assessed. The study included 1030 men and 492 women with a mean age of 67.5 ± 13.1 years. Of these, 92 had malignancy and 1430 did not; 45.7% of the former group and 16.0% of the latter group died by March 2015 (P < 0.01). Even after adjusting for various factors, presence of malignancy remained an independent risk factor for mortality (P < 0.01). Patients with performance status (PS) of 0 had significantly lower mortality (P < 0.01). Patients with malignancy at time of dialysis initiation had poor prognosis. Therefore, presence of malignancy should be taken into consideration when patients initiate dialysis. In patients with malignancy, better PS was associated with better prognosis.

AB - Patients with malignancy are reported to have poorer prognosis than those without malignancy. When patients with malignancy develop end-stage kidney disease, clinicians must determine treatment with consideration of prognosis. Furthermore, malignancy is sometimes found at time of dialysis initiation. However, prognosis of patients with malignancy at time of dialysis initiation has not been investigated. A total of 1524 patients with chronic kidney disease who initiated dialysis at 17 centers participating in the Aichi Cohort Study of Prognosis in Patients Newly Initiated into Dialysis were included. Patients initiated dialysis between October 2011 and September 2013. Mortality rates were compared between patients with and without malignancy. Types of malignancy and respective prognoses also were assessed. The study included 1030 men and 492 women with a mean age of 67.5 ± 13.1 years. Of these, 92 had malignancy and 1430 did not; 45.7% of the former group and 16.0% of the latter group died by March 2015 (P < 0.01). Even after adjusting for various factors, presence of malignancy remained an independent risk factor for mortality (P < 0.01). Patients with performance status (PS) of 0 had significantly lower mortality (P < 0.01). Patients with malignancy at time of dialysis initiation had poor prognosis. Therefore, presence of malignancy should be taken into consideration when patients initiate dialysis. In patients with malignancy, better PS was associated with better prognosis.

UR - http://www.scopus.com/inward/record.url?scp=85017383740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017383740&partnerID=8YFLogxK

U2 - 10.1111/1744-9987.12525

DO - 10.1111/1744-9987.12525

M3 - Article

C2 - 28322029

AN - SCOPUS:85017383740

VL - 21

SP - 345

EP - 353

JO - Therapeutic Apheresis and Dialysis

JF - Therapeutic Apheresis and Dialysis

SN - 1744-9979

IS - 4

ER -